It is conjectured that ENO1 acts as an upstream molecule in the PI3K/AKT pathway, and suppressing ENO1 can reduce the activation of the PI3K/AKT pathway and hinder the growth and spread of SK-Hep-1 liver cancer cells. Here, AKT1 is linked to liver cancer.